Approximately 70% of sporadic and nearly all ovarian cancers in
BRCA variant carriers are high-grade serous carcinomas (HGSCs),
1 which is the most lethal of the 5 main histotypes and has a 5-year survival rate less than 50%.
2 Although the general population lifetime risk of ovarian cancer is 1.4%,
3 individuals with an inherited germline
BRCA1 or
BRCA2 variant have average cumulative risks of 40% to 75% and 8% to 34%, respectively.
4 In
BRCA 1/2 variant carriers, bilateral salpingo-oophorectomy is recommended, which reduces the risk of ovarian or fallopian tube cancers by 80%.
5 Removal of the ovaries is not recommended for the general population because it is associated with increased total mortality, coronary heart disease, and osteoporosis.
6 Thus, a different preventive strategy is needed for individuals at average risk, who account for 80% of cases of HGSCs.